Registration for a live webinar on 'Precision medicine treatment for anticancer drug resistance' is now open.
See webinar detailsWe noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
- View the Talks
-
1. Traumatic brain injury: from the ball field to the battlefield
- Prof. Alan Faden
-
2. Avoiding missed diagnosis of mild traumatic brain injury
- Dr. John Bedolla
-
3. Basic mechanisms of spinal cord injury (SCI)
- Prof. Edward D. Hall
-
4. Neuroinflammation and spinal cord injury
- Prof. Phillip Popovich
-
6. Experimental approaches to developing and evaluating novel treatments for TBI and SCI
- Prof. W. Dalton Dietrich
-
7. The treatment of spinal cord injury: past, present and future
- Prof. James Fawcett
-
9. Promoting neuroplasticity for functional restoration after SCI
- Prof. Edelle Field-Fote
-
10. Physical rehabilitation after spinal cord injury: maximizing function
- Prof. Jennifer Hastings
-
11. Therapies for spinal cord injury: perspective from industry
- Dr. Andrew Blight
-
12. Spinal cord injury: some reflections on living with tetraplegia
- Prof. Jonathan Cole
-
13. Coping beyond adversity: living with a spinal cord injury
- Mr. Gary Allsop
-
14. Identifying the trauma footprint of acquired brain injury
- Dr. Christine Durham
-
15. Acquiring better insight into what it's like to have acquired brain injury
- Dr. Christine Durham
-
16. Molecular imaging in epilepsy
- Prof. Matthias Koepp
-
18. Rehabilitation of military related neurotrauma
- Dr. Michael Yochelson
-
19. Spinal cord injury in natural disasters
- Prof. Colleen O'Connell
Printable Handouts
Navigable Slide Index
- Introduction
- Spinal cord injury
- Treatments for spinal cord injury
- Need for suitable models
- Human spinal cord injuries (1)
- Human spinal cord injuries (2)
- Human SCI: age & sex
- Human SCI: spinal level of injury
- Human SCI: mechanisms of injury
- Experimental SCI models
- Potential sources of variance
- Weight drop devices
- Force controlled devices
- Depth of tissue penetration
- Position control: linear motors
- Linear motor based impactor
- Position controlled devices
- Consistency of initial lesions
- Primary tissue damage
- Timing of tissue loss after SCI
- Secondary tissue damage
- Secondary loss of grey matter
- Secondary loss of white matter (1)
- Secondary loss of white matter (2)
- Secondary loss of white matter (3)
- Secondary loss of oligodendrocytes (1)
- Secondary loss of oligodendrocytes (2)
- Assessing tissue sparing at lesion centre
- Assessing function: BBB score
- Assessing motor function
- Summary
- Acknowledgements
Topics Covered
- Development of neuro-protective therapies
- Need for suitable experimental models
- Low variance reproducible lesions
- Spatio-temporal pattern of grey and white matter damage
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Habgood, M. (2011, October 27). Experimental models for assessing treatments for spinal cord injury [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved December 21, 2024, from https://doi.org/10.69645/ATKS8762.Export Citation (RIS)
Publication History
Financial Disclosures
- Dr. Mark Habgood has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.